Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update

Alexandru Burlacu; Simonetta Genovesi; Alberto Ortiz; Christian Combe; Carlo Basile; Daniel Schneditz; Frank van der Sande; Grigore T. Popa; Cornel Morosanu; Adrian Covic; ERA-EDTA EUDIAL Working Group

doi:10.1093/ndt/gfz040

Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update

Alexandru Burlacu, Simonetta Genovesi, Alberto Ortiz, Christian Combe, Carlo Basile, Daniel Schneditz, Frank van der Sande, Grigore T. Popa, Cornel Morosanu, Adrian Covic^*, ERA-EDTA EUDIAL Working Group

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	923-933
Number of pages	11
Journal	Nephrology Dialysis Transplantation
Volume	34
Issue number	6
DOIs	https://doi.org/10.1093/ndt/gfz040
Publication status	Published - Jun 2019

Keywords

anticoagulants
antiplatelets
dialysis
G5D chronic kidney disease
guidelines
LOW-MOLECULAR-WEIGHT
ATRIAL-FIBRILLATION PATIENTS
ACUTE MYOCARDIAL-INFARCTION
DUAL ANTIPLATELET THERAPY
HEMODIALYSIS-PATIENTS
RENAL-DISEASE
WARFARIN USE
UNFRACTIONATED HEPARIN
VENOUS THROMBOEMBOLISM
FOCUSED UPDATE

Access to Document

10.1093/ndt/gfz040

Cite this

Burlacu, Alexandru ; Genovesi, Simonetta ; Ortiz, Alberto ; Combe, Christian ; Basile, Carlo ; Schneditz, Daniel ; van der Sande, Frank ; Popa, Grigore T. ; Morosanu, Cornel ; Covic, Adrian ; ERA-EDTA EUDIAL Working Group. / Pros and cons of antithrombotic therapy in end-stage kidney disease : a 2019 update. In: Nephrology Dialysis Transplantation. 2019 ; Vol. 34, No. 6. pp. 923-933.

@article{f91c59230ec7466c820cb9a9aa3fcc0f,

title = "Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update",

keywords = "anticoagulants, antiplatelets, dialysis, G5D chronic kidney disease, guidelines, LOW-MOLECULAR-WEIGHT, ATRIAL-FIBRILLATION PATIENTS, ACUTE MYOCARDIAL-INFARCTION, DUAL ANTIPLATELET THERAPY, HEMODIALYSIS-PATIENTS, RENAL-DISEASE, WARFARIN USE, UNFRACTIONATED HEPARIN, VENOUS THROMBOEMBOLISM, FOCUSED UPDATE",

author = "Alexandru Burlacu and Simonetta Genovesi and Alberto Ortiz and Christian Combe and Carlo Basile and Daniel Schneditz and {van der Sande}, Frank and Popa, {Grigore T.} and Cornel Morosanu and Adrian Covic and {ERA-EDTA EUDIAL Working Group}",

year = "2019",

month = jun,

doi = "10.1093/ndt/gfz040",

language = "English",

volume = "34",

pages = "923--933",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "6",

}

Pros and cons of antithrombotic therapy in end-stage kidney disease : a 2019 update. / Burlacu, Alexandru; Genovesi, Simonetta; Ortiz, Alberto; Combe, Christian; Basile, Carlo; Schneditz, Daniel; van der Sande, Frank; Popa, Grigore T.; Morosanu, Cornel; Covic, Adrian; ERA-EDTA EUDIAL Working Group.

In: Nephrology Dialysis Transplantation, Vol. 34, No. 6, 06.2019, p. 923-933.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Pros and cons of antithrombotic therapy in end-stage kidney disease

T2 - a 2019 update

AU - Burlacu, Alexandru

AU - Genovesi, Simonetta

AU - Ortiz, Alberto

AU - Combe, Christian

AU - Basile, Carlo

AU - Schneditz, Daniel

AU - van der Sande, Frank

AU - Popa, Grigore T.

AU - Morosanu, Cornel

AU - Covic, Adrian

AU - ERA-EDTA EUDIAL Working Group

PY - 2019/6

Y1 - 2019/6

KW - anticoagulants

KW - antiplatelets

KW - dialysis

KW - G5D chronic kidney disease

KW - guidelines

KW - LOW-MOLECULAR-WEIGHT

KW - ATRIAL-FIBRILLATION PATIENTS

KW - ACUTE MYOCARDIAL-INFARCTION

KW - DUAL ANTIPLATELET THERAPY

KW - HEMODIALYSIS-PATIENTS

KW - RENAL-DISEASE

KW - WARFARIN USE

KW - UNFRACTIONATED HEPARIN

KW - VENOUS THROMBOEMBOLISM

KW - FOCUSED UPDATE

U2 - 10.1093/ndt/gfz040

DO - 10.1093/ndt/gfz040

M3 - Editorial

C2 - 30879070

VL - 34

SP - 923

EP - 933

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 6

ER -